Day: December 6, 2022

San Pedro Property Location MapSan Pedro Property Drill Plan MapSan Pedro Property Section SP22-003VANCOUVER, British Columbia, Dec. 06, 2022 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) is pleased to announce that it has intersected significant silver mineralisation in the first hole (SP-22-003) drilled in 2022 on its wholly owned San Pedro Project located in Jalisco, Mexico (Figure 1). This hole intersected long intervals of brecciated rock from the collar. The mineralised zone was encountered close to surface, in the vicinity of historic mine workings at surface. The mineralised breccia units locally contain silicified fragments, found in a sericitic alteration. Base metal sulphides including galena and sphalerite occur in the matrix and in fragments of...

LOS ANGELES, Dec. 06, 2022 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Sidoti & Company December 2022 Small-Cap Virtual Conference on Wednesday, December 7, 2022 at 3:15 p.m. Eastern Time. There will be simultaneous and archived webcasts available at https://sidoti.zoom.us/webinar/register/WN_RmKSrQz8RAmz6EBj0rU0Zg and www.radnet.com under the “About RadNet” menu section and “News and Press Releases” sub-menu of the website. Details for RadNet’s Presentation: Date: Wednesday, December 7, 2022 Time: 3:15 p.m. Eastern Time URL: https://sidoti.zoom.us/webinar/register/WN_RmKSrQz8RAmz6EBj0rU0Zg About...

In November 2022, the number of Icelandair‘s passengers was just over 250 thousand, compared to 170 thousand in November last year. Capacity in November was 96% of 2019 levels.  The number of passengers on international flights was 227 thousand compared to 151 thousand in November 2021, an increase of 50%. The number of passengers to Iceland was 95 thousand and from Iceland 49 thousand. Via passengers were around 82 thousand. On time performance on international flights was 91%. The load factor on international flights was 73%, compared to 71% in November 2021. The number of passengers on domestic flights was 23 thousand, compared to 19 thousand in November 2021. On time performance was 87%. The load factor on domestic flights was 76% compared to 79% in November 2021. Sold block hours in charter flights increased by 11%. Freight measured...

Regulated informationIssy-les-Moulineaux, December 6, 2022 Monthly disclosure on share capital and voting rightsPursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorités des Marchés Financiers Registered name of the issuer: SODEXO255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUXDate Total number of shares Actual voting rights * Theoretical voting rights **November 30, 2022147,454,887217,231,612218,676,270* Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights.** Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having...

Presentation on Thursday, December 8th, 2022, at 10:00 am EST Sheridan, Wyoming, Dec. 06, 2022 (GLOBE NEWSWIRE) — Rogue Station Companies/Everdime, Inc. (OTC Pink: RGST) is pleased to announce that it will be presenting virtually at the upcoming Sequire Virtual Small Cap Conference on Thursday, December 8th, at 00:00 AM/PM ET. Sandor Miklos CEO and Simon Smith CTO of Everdime, will be giving the presentation. Sandor Miklos, Everdime, Inc’s CEO commented, “We are looking forward to presenting at the Sequire Small Cap conference. We will be providing additional information about Everdime’s Web3 onboarding solutions for enterprise. While Web3 is in its nascent stage it is expected to grow rapidly in the coming years. Everdime intends to be part of the exciting industry, leverage its expertise, capture revenue by providing white label...

OSLO, Norway, Dec. 06, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that it has entered into a clinical collaboration and supply agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA), to evaluate Nykode’s wholly-owned lead candidate, VB10.16, in combination with MSD’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in a Phase 1/2a trial in patients with HPV16-positive head and neck cancer. VB10.16 is an off-the-shelf therapeutic cancer vaccine specifically designed to treat HPV16-induced malignancies. The candidate has reported interim data from a Phase 2 trial in heavily pre-treated cervical cancer patients (NCT04405349). The analysis demonstrated a favorable safety profile, with responses...